IP Verse

Angiopoietin-Like 3 (Angptl3) Irna Compositions And Methods Of Use Thereof

Patent No. EP3656860 (titled "Angiopoietin-Like 3 (Angptl3) Irna Compositions And Methods Of Use Thereof") was filed by Alnylam Pharmaceuticals on Jun 20, 2012. The application was issued on Apr 20, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GRUNECKER PATENT UND RECHTSANWALTE PARTG MBBJan 20, 2023GRUNECKER PATENT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3656860

ALNYLAM PHARMACEUTICALS
Application Number
EP19192281A
Filing Date
Jun 20, 2012
Status
Granted And Under Opposition
Mar 18, 2022
Publication Date
Apr 20, 2022
External Links
Slate, Register , Google Patents